Cabot (CBT) Set to Announce Earnings on Monday

Cabot (NYSE:CBT - Get Free Report) is scheduled to release its earnings data after the market closes on Monday, November 4th. Analysts expect Cabot to post earnings of $1.82 per share for the quarter. Cabot has set its FY24 guidance at $7.00-$7.10 EPS.Persons interested in participating in the company's earnings conference call can do so using this link.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.20. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1 billion. During the same period in the prior year, the company posted $1.42 EPS. The firm's quarterly revenue was up 5.0% compared to the same quarter last year. On average, analysts expect Cabot to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cabot Stock Up 0.9 %

NYSE:CBT traded up $1.01 during mid-day trading on Monday, hitting $110.27. 262,243 shares of the company's stock traded hands, compared to its average volume of 331,523. The company has a fifty day moving average of $107.59 and a 200 day moving average of $100.41. Cabot has a twelve month low of $65.38 and a twelve month high of $117.14. The company has a market capitalization of $6.09 billion, a P/E ratio of 13.96, a P/E/G ratio of 0.93 and a beta of 1.19. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22.

Insider Activity

In other news, CEO Sean D. Keohane sold 25,617 shares of the company's stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the sale, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the transaction, the chief financial officer now owns 59,814 shares in the company, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sean D. Keohane sold 25,617 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares in the company, valued at $33,630,719.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 71,939 shares of company stock valued at $7,308,812. Company insiders own 3.07% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CBT. UBS Group reduced their target price on Cabot from $103.00 to $98.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 6th. JPMorgan Chase & Co. increased their price objective on Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a report on Wednesday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Cabot presently has an average rating of "Hold" and an average target price of $101.75.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.